Pharmaceutical Preparations · DE · CIK 1676725
Oncology-focused precision medicine company discovering and developing targeted therapeutics for patient populations selected using molecular diagnostics
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 1 insider bought $1.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Stein JeffreyDirector | Buy | 50,000 | $32.96 | $1.6M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.